advertisement
11.8 Neuroprotection (259)
Showing records 1 to 25
Display all abstracts in classification 11.8 Neuroprotection
Search within classification 11.8 Neuroprotection70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Lv B
Journal of Glaucoma 2016; 25: e792-e801
70331 Generation of Functional Human Retinal Ganglion Cells with Target Specificity from Pluripotent Stem Cells by Chemically Defined Recapitulation of Developmental Mechanism
Teotia P
Stem Cells 2017; 35: 572-585
70615 Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model
Huang S
Neuroscience 2017; 341: 27-41
70577 The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection
Yamamoto K
Journal of Neurochemistry 2017; 140: 495-508
70193 Dock3-NMDA receptor interaction as a target for glaucoma therapy
Kimura A
Histology and Histopathology 2017; 32: 215-221
70234 Is glaucoma a mitochondrial neurodegenerative disease
Zhang Z
Chinese Journal of Ophthalmology 2016; 52: 714-717
70585 Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma
Dong Z
Heliyon 2016; 2: e00191
70277 Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma
Guo X
Scientific reports 2016; 6: 33950
70706 Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective
Lim JC
Frontiers in cellular neuroscience 2016; 10: 270
70125 Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension
Ou Y
Journal of Neuroscience 2016; 36: 9240-9252
70158 The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Ozaki T
Biochemical and Biophysical Research Communications 2016; 478: 1700-1705
70385 Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
Xu Y
Oncotarget 2016; 7: 72503-72517
70695 Palmitic acid triggers cell apoptosis in RGC-5 retinal ganglion cells through the Akt/FoxO1 signaling pathway
Yan P
Metabolic brain disease 2017; 32: 453-460
70042 Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma
Wang ZF
Acta physiologica Sinica 2016; 68: 483-491
70705 Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma
Breen KT
Frontiers in neuroscience 2016; 10: 526
70709 Alteration of Neurotrophic Factors After Transplantation of Bone Marrow Derived Lin-ve Stem Cell in NMDA-Induced Mouse Model of Retinal Degeneration
Jindal N
Journal of Cellular Biochemistry 2017; 118: 1699-1711
70733 Neuroprotection for glaucoma: Requirements for clinical translation
Levin LA
Experimental Eye Research 2017; 157: 34-37
70574 Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma
Wilson GN
Frontiers in neuroscience 2016; 10: 494
70673 Role of cyclic AMP in the eye of glaucoma
Shim MS
BMB reports 2017; 50: 60-70
70775 Why autophagy is good for retinal ganglion cells?
Boya P
Eye 2017; 31: 185-190
70047 In vitro bioassay model for screening non-viral neurotrophic factor gene delivery systems for glaucoma treatment
Chen DW
Drug delivery and translational research 2016; 6: 676-685
70646 Neuro-rejuvenation for neuronal function
Liu Y
Neural Regeneration Research 2016; 11: 1560-1563
70341 Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells
Xue B
Experimental Eye Research 2016; 153: 42-50
70626 Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity
Tsutsumi T
Investigative Ophthalmology and Visual Science 2016; 57: 6461-6473
70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Wang X
Drug design, development and therapy 2016; 10: 3449-3457
